The Importance of Prompt Diagnosis and Referral

The PCP is in a key position to recognize RA or Psoriatic Arthritis sooner

As a primary care physician, you may be the first physician a patient sees when he or she experiences symptoms of rheumatoid arthritis (RA) or psoriatic arthritis. Studies have shown that over half of patients suffer from joint damage by the time they are diagnosed with these diseases, so it is crucial that these patients are referred to a rheumatologist as soon as possible, to inhibit further progression.1-7

Serial x-rays show structural damage of RA over time8

Serial x-rays show structural damage of RA over time
Changes can be seen in joints of the hands, beginning with (A) the swelling of the soft tissue, but with intact underlying cortex and no erosions.
This is followed by (B) thinning of the radial side of the cortex with minimal disturbance of underlying trabeculae and minimal joint space narrowing.
A marginal erosion (C) appears on the radial aspect of the metacarpal head. There is loss of bone substance and joint space narrowing.
©2009 American College of Rheumatology. Images used with permission.

The earlier that RA and psoriatic arthritis are diagnosed, the sooner treatment can be initiated that can help inhibit progression of joint damage. If a patient appears to be experiencing symptoms of RA or psoriatic arthritis, refer them to a rheumatologist as soon as possible.3-6

Symptoms to watch for

RA symptoms may include:9-11

  • Morning joint stiffness
  • Joint pain
  • Joint swelling, commonly observed in the hands
  • Weakness
  • Fatigue

Psoriatic arthritis symptoms may include:12-14

  • Swelling of an entire finger or toe
  • General joint pain, stiffness, and swelling
  • Back pain and stiffness (lower back, neck, and upper back)
  • Psoriatic skin lesions (raised, red patches, often covered with silvery white scales)
  • Changes in the nails: pitting is commonly seen in the fingernails and toenails of 90% of people with psoriatic arthritis

Help your patients prepare for their appointment with a rheumatologist

This downloadable conversation guide is designed to help patients prepare for their appointment with a rheumatology specialist. Questions include, "What are my treatment options for RA?" and "When can I expect results?"

Download Conversation Guide for Patients and Rheumatologists

RAConversations is a video series created to demonstrate common discussions that a patient may have with a rheumatology specialist, from questions about the condition to information about taking ENBREL for moderate to severe RA.

View RAConversations

Browse additional patient support materials

Important Safety Information Prescribing Information Medication Guide
Indications
 
Moderate to Severe Rheumatoid Arthritis Supportive Data Psoriatic Arthritis Supportive Data
Safety Information ISI

ENBREL offers the convenience and flexibility of 4 injection options

Show your patients video demonstrations of each self-administration method.

View ENBREL dosing and administration

ENBREL Support™ offers financial support to new or continuing eligible patients*

No out-of-pocket costs for 6 months for new ENBREL Support™ card members.

Learn about our program
*Eligibility: Open to patients with commercial prescription insurance. Not open to uninsured patients or patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare including Medicare Part D, Medicaid, etc.) or patients who live in Massachusetts (or where prohibited by law). Restrictions, including monthly maximums, may apply. Offer subject to change or discontinuation without notice.
Phil Mickelson, Champion golfer and ENBREL PsA patient since 2010
 
 
Close
You are leaving Enbrel.com/RheumPro
Please know that Amgen and Pfizer do not endorse and are not responsible for the content included on the site you are about to enter. Click the "Continue" button to proceed.

To return to ENBREL.com, click "Cancel" or close this window.

Privacy Policy  Terms of Use
This site is intended for US Audiences only.
©2011 Amgen, Inc., Thousand Oaks, CA 91320 and Pfizer Inc
Close
E-mail this page to a colleague
Please correct the fields marked in red
Send
This content is for US health care professionals only. Amgen and Pfizer will not use your e-mail address or your colleague's e-mail address for any other purpose. To learn more about our use of your information and your rights, please consult our Privacy Policy.
Close

Send another e-mail
Return to enbrel.com/RheumPro

Close
Notice

The following information is intended for use only by residents of the United States. Countries outside of the United States may have regulatory requirements or medical practices that are different than those in the United States and may require reference to different or additional information. Therefore, this information may not be appropriate outside of the United States.

If you are a resident of the United States or one of its territories, or a health care professional practicing your profession in the United States or one of its territories, please click below.

If you are a resident of a country other than the United States, please visit the Pfizer website and the Amgen website to find information about our offices around the globe.
Close
Disease activity vs. structural progression in RA